# Truenat™ HCV RNA Assay Evaluation

> **NCT04236973** · NA · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 1330 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DEVICE:** Molbio Truenat™ HCV assay (the investigational product)
- **OTHER:** Abbott RealTime HCV assay

## Key facts

- **NCT ID:** NCT04236973
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-12
- **Primary completion:** 2021-07-20
- **Final completion:** 2021-07-20
- **Target enrollment:** 1330 (ACTUAL)
- **Last updated:** 2021-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04236973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04236973, "Truenat™ HCV RNA Assay Evaluation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04236973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*